• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组盘尾丝虫抗原在人体盘尾丝虫病诊断和监测中的应用。

Use of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis.

作者信息

Chandrashekar R, Ogunrinade A F, Weil G J

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Trop Med Int Health. 1996 Oct;1(5):575-80. doi: 10.1111/j.1365-3156.1996.tb00082.x.

DOI:10.1111/j.1365-3156.1996.tb00082.x
PMID:8911441
Abstract

The diagnostic value of ELISAs based on recombinant Onchocerca volvulus antigens OC 3.6 and OC 9.3 was evaluated with sera from endemic areas in West Africa, Guatemala and Ecuador. IgG assays were slightly more sensitive than those that detected IgG4, and the antigen combination was significantly more sensitive than either antigen alone (OC 3.6, 93%; OC 9.3, 84%, combined 98%). These assays were also evaluated with sera from 2 villages in the Onchocerciasis Control Programme area of West Africa including one village (Pendie) with recent recrudescence of infection and one (Niarba) where transmission had been interrupted for 15 years by vector control. The OC 3.6 IgG antibody assay was sensitive for new infections and exposure in Pendie; 24/24 (100%) of people with positive skin snips and 15/74 (20%) of sera from MF negative people had IgG antibodies to this antigen. In addition, antibodies to OC 3.6 often preceded the onset of skin snip positivity in Pendie. In contrast, IgG antibodies to OC 3.6 and OC 9.3 were rarely seen in children born during the 15 years since transmission was interrupted by vector control in Niarba. These encouraging results suggest that antibody assays based on OC 3.6 and OC 9.3 may be valuable tools for surveillance of onchocerciasis and also for monitoring the efficacy of control programmes.

摘要

采用来自西非、危地马拉和厄瓜多尔流行地区的血清,评估了基于重组盘尾丝虫抗原OC 3.6和OC 9.3的酶联免疫吸附测定(ELISA)的诊断价值。IgG检测比检测IgG4的检测略敏感,并且抗原组合比单独任何一种抗原都显著更敏感(OC 3.6,93%;OC 9.3,84%,联合检测为98%)。还采用来自西非盘尾丝虫病控制项目地区2个村庄的血清对这些检测进行了评估,其中一个村庄(彭迪)近期感染复发,另一个村庄(尼亚尔巴)通过病媒控制已中断传播15年。OC 3.6 IgG抗体检测对彭迪的新感染和暴露敏感;24/24(100%)皮肤切片阳性者和15/74(20%)微丝蚴阴性者的血清具有针对该抗原的IgG抗体。此外,在彭迪,针对OC 3.6的抗体通常先于皮肤切片阳性出现。相比之下,自尼亚尔巴通过病媒控制中断传播后的15年里出生的儿童中,很少见到针对OC 3.6和OC 9.3的IgG抗体。这些令人鼓舞的结果表明,基于OC 3.6和OC 9.3的抗体检测可能是盘尾丝虫病监测以及控制项目效果监测的有价值工具。

相似文献

1
Use of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis.重组盘尾丝虫抗原在人体盘尾丝虫病诊断和监测中的应用。
Trop Med Int Health. 1996 Oct;1(5):575-80. doi: 10.1111/j.1365-3156.1996.tb00082.x.
2
Preliminary evaluation of recombinant Onchocerca volvulus antigens for serodiagnosis of onchocerciasis.用于盘尾丝虫病血清学诊断的重组盘尾丝虫抗原的初步评估。
J Clin Microbiol. 1993 Jul;31(7):1741-5. doi: 10.1128/jcm.31.7.1741-1745.1993.
3
Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of Infection.评估 OV-16 IgG4 酶联免疫吸附试验在人类中的应用及其在感染非人灵长类动物模型中确定抗体反应动力学的应用。
Am J Trop Med Hyg. 2018 Oct;99(4):1041-1048. doi: 10.4269/ajtmh.18-0132.
4
Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.盘尾丝虫感染期间儿童的免疫球蛋白G亚类反应。
Clin Diagn Lab Immunol. 1996 Jan;3(1):98-104. doi: 10.1128/cdli.3.1.98-104.1996.
5
Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal.在塞内加尔盘尾丝虫病监测中使用SD BIOLINE盘尾丝虫病IgG4快速检测的可行性。
PLoS Negl Trop Dis. 2017 Oct 3;11(10):e0005884. doi: 10.1371/journal.pntd.0005884. eCollection 2017 Oct.
6
The role of a recombinant hybrid protein based ELISA for the serodiagnosis of Onchocerca volvulus.基于重组杂交蛋白的酶联免疫吸附测定法在盘尾丝虫病血清学诊断中的作用。
J Clin Pathol. 2008 Mar;61(3):347-51. doi: 10.1136/jcp.2006.037093. Epub 2007 Oct 8.
7
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.盘尾丝虫感染不同阶段人类免疫的多样表达。
Immunology. 1997 Apr;90(4):592-9. doi: 10.1046/j.1365-2567.1997.00210.x.
8
Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapid-format antibody card test.盘尾丝虫抗体检测试验:间接酶联免疫吸附试验中使用的重组抗原混合物与快速抗体卡片试验敏感性的比较。
Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):539-41. doi: 10.1016/s0035-9203(03)80018-4.
9
Effect of ivermectin prophylaxis on antibody responses to Onchocerca volvulus recombinant antigens in experimentally infected chimpanzees.伊维菌素预防对实验感染黑猩猩体内抗盘尾丝虫重组抗原抗体反应的影响。
Int J Parasitol. 1995 Aug;25(8):983-8. doi: 10.1016/0020-7519(95)00011-p.
10
Evaluation of the Diagnostic Performance of Linear Epitopes in a Peptide Enzyme-Linked Immunosorbent Assay.线性表位在肽酶联免疫吸附试验中的诊断性能评估。
Am J Trop Med Hyg. 2018 Mar;98(3):779-785. doi: 10.4269/ajtmh.17-0756. Epub 2018 Jan 4.

引用本文的文献

1
Whole blood transcriptome analysis in onchocerciasis.盘尾丝虫病的全血转录组分析
Curr Res Parasitol Vector Borne Dis. 2022 Aug 9;2:100100. doi: 10.1016/j.crpvbd.2022.100100. eCollection 2022.
2
Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring.用于盘尾丝虫病诊断和监测的多表位抗原(OvMCBL02)的免疫信息学设计与评估
Diagnostics (Basel). 2022 Jun 11;12(6):1440. doi: 10.3390/diagnostics12061440.
3
Multimodal biomarker discovery for active Onchocerca volvulus infection.
多模态生物标志物在活旋毛虫感染中的发现。
PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0009999. doi: 10.1371/journal.pntd.0009999. eCollection 2021 Nov.
4
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.用于人类盘尾丝虫病诊断的嵌合抗原OvMANE1的计算机辅助设计与验证
Pathogens. 2020 Jun 22;9(6):495. doi: 10.3390/pathogens9060495.
5
Regulatory effect of two Trichinella spiralis serine protease inhibitors on the host's immune system.旋毛虫丝氨酸蛋白酶抑制剂对宿主免疫系统的调控作用。
Sci Rep. 2019 Nov 19;9(1):17045. doi: 10.1038/s41598-019-52624-5.
6
Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23.土壤传播性蠕虫和曼氏血吸虫的专利感染与抗盘尾丝虫多肽表位 OvMP-1 和 OvMP-23 的抗体阳性率增加无关。
Parasit Vectors. 2019 Jan 28;12(1):63. doi: 10.1186/s13071-019-3308-z.
7
Diagnostics for onchocerciasis in the era of elimination.消除盘尾丝虫病时代的盘尾丝虫病诊断方法
Int Health. 2018 Mar 1;10(suppl_1):i20-i26. doi: 10.1093/inthealth/ihx047.
8
Evaluation of the Diagnostic Performance of Linear Epitopes in a Peptide Enzyme-Linked Immunosorbent Assay.线性表位在肽酶联免疫吸附试验中的诊断性能评估。
Am J Trop Med Hyg. 2018 Mar;98(3):779-785. doi: 10.4269/ajtmh.17-0756. Epub 2018 Jan 4.
9
Plasma-derived parasitic microRNAs have insufficient concentrations to be used as diagnostic biomarker for detection of Onchocerca volvulus infection or treatment monitoring using LNA-based RT-qPCR.血浆来源的寄生微小RNA浓度不足以用作基于锁核酸(LNA)的逆转录定量聚合酶链反应(RT-qPCR)检测盘尾丝虫感染或监测治疗的诊断生物标志物。
Parasitol Res. 2017 Mar;116(3):1013-1022. doi: 10.1007/s00436-017-5382-5. Epub 2017 Jan 22.
10
An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies.一种用于检测皮肤活检样本中盘尾丝虫感染的等温DNA扩增方法。
Parasit Vectors. 2016 Dec 1;9(1):624. doi: 10.1186/s13071-016-1913-7.